Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of <scp>CALGB</scp> (Alliance) 10301, a multicentre phase <scp>II</scp> study
- DOI
- 10.1111/bjh.13592
- Published
- 2015-07-22
- Container
- British Journal of Haematology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/bjh.13592,
title = {Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of <scp>CALGB</scp> (Alliance) 10301, a multicentre phase <scp>II</scp> study},
author = {Peter M. Voorhees and Robert Z. Orlowski and Flora Mulkey and Peter Watson and Susan Geyer and Ben L. Sanford and Elizabeth Bennett and Asher A. Chanan‐Khan and Clara D. Bloomfield and Richard A. Larson},
year = {2015},
journal = {British Journal of Haematology},
doi = {10.1111/bjh.13592},
url = {https://doi.org/10.1111/bjh.13592}
}RIS
TY - JOUR TI - Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of <scp>CALGB</scp> (Alliance) 10301, a multicentre phase <scp>II</scp> study AU - Peter M. Voorhees AU - Robert Z. Orlowski AU - Flora Mulkey AU - Peter Watson AU - Susan Geyer AU - Ben L. Sanford AU - Elizabeth Bennett AU - Asher A. Chanan‐Khan AU - Clara D. Bloomfield AU - Richard A. Larson PY - 2015 JO - British Journal of Haematology DO - 10.1111/bjh.13592 UR - https://doi.org/10.1111/bjh.13592 ER -
APA
Voorhees, P. M., Orlowski, R. Z., Mulkey, F., Watson, P., Geyer, S., Sanford, B. L., Bennett, E., Chanan‐Khan, A. A., Bloomfield, C. D., & Larson, R. A. (2015). Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of <scp>CALGB</scp> (Alliance) 10301, a multicentre phase <scp>II</scp> study. British Journal of Haematology. https://doi.org/10.1111/bjh.13592
Source records
- crossref · retrieved 2026-09-27T06:15:29.344Z